These discoveries open a new therapeutic possibility for various inflammatory and autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease, and autoimmune uveitis; increased IL-24 expression in addition to IL-17A could be a possible therapeutic strategy. This evidence concerns the gene IL17A and autoimmune disease.